Serpin peptidase inhibitor (SERPINB5) haplotypes are associated with susceptibility to hepatocellular carcinoma

Scientific Reports

Volumn 6, Issue 1, 2016, Pages

  Yang, Shun Fa ^a,b   Yeh, Chao Bin ^a,b   Chou, Ying Erh ^a,b   Lee, Hsiang Lin ^a,b   Liu, Yu Fan ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

SERINE PROTEINASE INHIBITOR; SERPIN-B5; TUMOR MARKER; TUMOR PROTEIN;

AGED; ALLELE; CLINICAL TRIAL; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETICS; HAPLOTYPE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALLELES; BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; FEMALE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; SERPINS;

EID: 85013751129     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep26605     Document Type: Article

References (51)

1. Torre, L. A. et al. Global cancer statistics, 2012. CA Cancer J Clin 65, 87–108 (2015).
2. Bosch, F. X., Ribes, J., Díaz, M. & Cléries, R. Primary liver cancer: Worldwide incidence and trends. Gastroenterology 127, S5–S16 (2004).
3. Tsai, W. L. & Chung, R. T. Viral hepatocarcinogenesis. Oncogene 29, 2309–2324 (2010).
4. Farazi, P. A. & DePinho, R. A. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6, 674–687 (2006).
5. Wang, L. Y. et al. Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan. Cancer Causes Control 14, 241–250 (2003).
6. Altamirano, J. & Bataller, R. Cigarette smoking and chronic liver diseases. Gut 59, 1159–1162 (2010).
7. Wong, V. W. et al. Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers. J Clin Oncol 28, 1660–1665 (2010).
8. Asahina, Y. et al. Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection. Hepatology 52, 518–527 (2010).
9. Lee, C. M. et al. Age, gender and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection. Cancer 86, 1143–1150 (1999).
10. Chan, S. L., Wong, V. W., Qin, S. & Chan, H. L. Infection and Cancer: The Case of Hepatitis B. J Clin Oncol 34, 83–90 (2016).
11. Zou, Z. et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263, 526–529 (1994).
12. Blacque, O. E. & Worrall, D. M. Evidence for a direct interaction between the tumor suppressor serpin, maspin and types I and III collagen. J Biol Chem 277, 10783–10788 (2002).
13. Sheng, S. et al. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci USA 93, 11669–11674 (1996).
14. Vecchi, M. et al. Breast cancer metastases are molecularly distinct from their primary tumors. Oncogene 27, 2148–2158 (2008).
15. Teoh, S. S., Whisstock, J. C. & Bird, P. I. Maspin (SERPINB5) is an obligate intracellular serpin. J Biol Chem 285, 10862–10869 (2010).
16. Bal, N., Kocer, N. E., Ertorer, M. E., Canpolat, E. T. & Kayaselcuk, F. Maspin, E-selectin and P-selectin expressions in papillary thyroid carcinomas and their correlation with prognostic parameters. Pathology, research and practice 204, 743–750 (2008).
17. Berardi, R. et al. Role of maspin in cancer. Clin Transl Med 2, 8 (2013).
18. Bascones-Martinez, A. et al. Differences in the expression of five senescence markers in oral cancer, oral leukoplakia and control samples in humans. Oncol Lett 3, 1319–1325 (2012).
19. Nickoloff, B. J. et al. Tumor suppressor maspin is up-regulated during keratinocyte senescence, exerting a paracrine antiangiogenic activity. Cancer Res 64, 2956–2961 (2004).
20. Sheng, S. A role of novel serpin maspin in tumor progression: the divergence revealed through efforts to converge. J Cell Physiol 209, 631–635 (2006).
21. Law, R. H. et al. The high resolution crystal structure of the human tumor suppressor maspin reveals a novel conformational switch in the G-helix. J Biol Chem 280, 22356–22364 (2005).
22. Feitelson, M. A. Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma. Cancer Lett 239, 10–20 (2006).
23. Thorgeirsson, S. S. & Grisham, J. W. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31, 339–346 (2002).
24. Li, M. X. et al. Prognostic Role of Glasgow Prognostic Score in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Medicine (Baltimore) 94, e2133 (2015).
25. Genomes Project, C. et al. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56–65 (2012).
26. Barrett, J. C., Fry, B., Maller, J. & Daly, M. J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263–265 (2005).
27. Zou, Z. et al. p53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem 275, 6051–6054 (2000).
28. Kim, S., Han, J., Kim, J. & Park, C. Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression. Cancer Res 64, 6900–6905 (2004).
29. Kellis, M. et al. Defining functional DNA elements in the human genome. Proc Natl Acad Sci USA 111, 6131–6138 (2014).
30. Dreos, R., Ambrosini, G., Cavin Perier, R. & Bucher, P. EPD and EPDnew, high-quality promoter resources in the next-generation sequencing era. Nucleic Acids Res 41, D157–164 (2013).
31. Al-Ayyoubi, M., Gettins, P. G. & Volz, K. Crystal structure of human maspin, a serpin with antitumor properties: reactive center loop of maspin is exposed but constrained. J Biol Chem 279, 55540–55544 (2004).
32. Yin, S., Ding, F. & Dokholyan, N. V. Eris: an automated estimator of protein stability. Nat Methods 4, 466–467 (2007).
33. Baert-Desurmont, S. et al. Clinical relevance of 8q23, 15q13 and 18q21 SNP genotyping to evaluate colorectal cancer risk. European journal of human genetics: EJHG 24, 99–105 (2016).
34. Cai, T. et al. Loss of heterozygosis on chromosome 18q21-23 and muscle-invasive bladder cancer natural history. Oncol Lett 10, 2569–2573 (2015).
35. Shiiba, M. et al. Down-regulated expression of SERPIN genes located on chromosome 18q21 in oral squamous cell carcinomas. Oncology reports 24, 241–249 (2010).
36. Kim, M., Ju, H., Lim, B. & Kang, C. Maspin genetically and functionally associates with gastric cancer by regulating cell cycle progression. Carcinogenesis 33, 2344–2350 (2012).
37. Nakagawa, M. et al. Maspin expression and its clinical significance in non-small cell lung cancer. Ann Surg Oncol 13, 1517–1523 (2006).
38. Abd El-Maqsoud, N. M. & Tawfiek, E. R. Loss of Maspin Expression in Bladder Cancer: Its Relationship with p53 and Clinicopathological Parameters. J Egypt Natl Canc Inst 22, 1–12 (2010).
39. Kim, J. H. et al. Nuclear maspin expression correlates with the CpG island methylator phenotype and tumor aggressiveness in colorectal cancer. Int J Clin Exp Pathol 8, 1920–1928 (2015).
40. Meng, H. et al. Association between SNPs in Serpin gene family and risk of esophageal squamous cell carcinoma. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine 36, 6231–6238 (2015).
41. Jang, H. L. et al. Maspin polymorphism associated with apoptosis susceptibility and in vivo tumorigenesis. Int J Mol Med 22, 333–338 (2008).
42. Sastre, J. et al. Clinical guideline SEOM: hepatocellular carcinoma. Clin Transl Oncol 17, 988–995 (2015).
43. Bruix, J. & Sherman, M. & American Association for the Study of Liver, D. Management of hepatocellular carcinoma: an update. Hepatology 53, 1020–1022 (2011).
44. Zavras, A. I., Yoon, A. J., Chen, M. K., Lin, C. W. & Yang, S. F. Metallothionein-1 genotypes in the risk of oral squamous cell carcinoma. Ann Surg Oncol 18, 1478–1483 (2011).
45. Glad, C. A., Johannsson, G., Carlsson, L. M. & Svensson, P. A. Rapid and high throughput genotyping of the growth hormone receptor exon 3 deleted/full-length polymorphism using a tagSNP. Growth Horm IGF Res 20, 270–273 (2010).
46. Ward, L. D. & Kellis, M. HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease. Nucleic Acids Res 44, D877–881 (2016).
47. Consortium, G. T. The Genotype-Tissue Expression (GTEx) project. Nat Genet 45, 580–585 (2013).
48. Pazin, M. J. Using the ENCODE Resource for Functional Annotation of Genetic Variants. Cold Spring Harb Protoc 2015, 522–536 (2015).
49. Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2, 401–404 (2012).
50. Goldman, M. et al. The UCSC Cancer Genomics Browser: update 2015. Nucleic Acids Res 43, D812–817 (2015).
51. Rose, P. W. et al. The RCSB Protein Data Bank: views of structural biology for basic and applied research and education. Nucleic Acids Res 43, D345–356 (2015).